Purchase Order 75N95019P00647
Award Date
9/12/19
Potential Completion Date
2/1/21
Potential Value
$83K
Federal Agency
National Institute on Drug Abuse
Awardee
The Johns Hopkins University
Ultimate Awardee
Not listed
PSC Category
B529 - Special Studies/Analysis- Scientific Data
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Baltimore, MD 21205, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The National Institutes of Health's National Institute on Drug Abuse awarded a $32,720 purchase order to The Johns Hopkins University for gene sequencing and profiling of sample tissue. This firm fixed price contract supports the NIH/NIDA's biomedical research efforts through Johns Hopkins' delivery of genomic analysis services. No subcontractors or set aside designations were identified. The one year period of performance begins in July 2023, with work conducted at Johns Hopkins' Bethesda,...
This is a $75,000 firm fixed-price purchase order contract awarded by the National Institute on Aging (NIA), a civilian agency, to The Johns Hopkins University to perform single-cell RNA deep sequencing. The contract aims to measure gene expression changes in primary human peripheral blood cells that occur with age as part of an ongoing project called GESTALT. Johns Hopkins will sequence 10,000 single cell samples per study participant to obtain 500 million reads per sample using Illumina's...
This firm-fixed-price purchase order was awarded by the National Institute on Aging (NIA), a civilian agency, to The Johns Hopkins University for $358,152.00. The contract is for performing mouse whole genome bisulfite sequencing, bulk RNA sequencing to support immune cell gene regulation research, and single-cell RNA sequencing to support Alzheimer's disease-related dementias research. The period of performance is from September 2020 to September 2022. This contract was not set aside and was...
This is a $126,000.00 firm fixed price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services, to The Johns Hopkins University in Baltimore, Maryland. The contract is for JHMI DEEP SEQUENCING AND MICROARRAY CORE services and has an ultimate completion date of December 31, 2017. The award was made on September 23, 2016 and does not utilize a set-aside. The Johns Hopkins University is a private...
This is a firm fixed price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the Department of Health and Human Services, to Illumina, Inc. The $133,624.15 contract is for the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, accompanying reagents and consumables, sample prep kits, sequencing chips, support plans, maintenance services, and bioinformatics products. The contract has a period of performance through...
This is a $78,707.44 firm fixed price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), to Illumina, Inc. The contract does not have a set-aside designation. Illumina, a manufacturer and provider of sequencing and array-based solutions for genetic and genomic analysis, is providing various sequencing systems, reagents, consumables, and other support services to NIDA under this award. Illumina has previously received...
This is a firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), to Illumina, Inc. The $292,500.00 contract is for the provision of Illumina sequencing systems, reagents, and associated products and services to support genomic sequencing and analysis. Illumina is an experienced provider of sequencing and genomic analysis technologies to federal agencies, having previously supported work at the NIH, Centers for...
This firm fixed-price purchase order was awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to Illumina, Inc., a for-profit manufacturer of genomic sequencing systems and consumables. The $729,384.93 contract supports the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing instruments, reagents, and bioinformatics products to NIDA. This appears to be a standalone contract award, rather than being associated with a...
This firm fixed-price purchase order for $306,030.00 was awarded by the National Institute on Drug Abuse (NIDA), a civilian agency under the Department of Health and Human Services (HHS), to Illumina, Inc. The contract is for the provision of a sequencing instrument required for high-output sequencing gene expression analysis, under the Major Program Code "SEQUENCING INSTRUMENT REQUIRED FOR HIGH-OUTPUT SEQUENCING GENE EXPRESSION ANALYSIS". The award has a completion date of December...
This is a firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of genetic sequencing and genomic analysis instruments and consumables. The award, valued at $12,524.80, is for the delivery of Illumina sequencing systems and related products to support NIDA's research and diagnostics needs. This award is not associated with a set-aside program. Illumina has received multiple...